Matinas BioPharma Holdings (MTNB) Depreciation & Amortization (CF) (2013 - 2026)
Matinas BioPharma Holdings' Depreciation & Amortization (CF) came in at $1,000 for Q2 2026, down 91.7% from $12,000 a year earlier.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Matinas BioPharma Holdings reported Depreciation & Amortization (CF) of $15,000, down 92.9% year-over-year; for FY2025, it was $32,000, down 91.2% from FY2024.
- Depreciation & Amortization (CF) carries a five-year compound annual growth rate of -32.7% (FY2020 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $365,000 in FY2024 (-5.2%), $385,000 in FY2023 (+14.2%), $337,000 in FY2022 (+38.1%) and $244,000 in FY2021 (+5.6%).
- The five-year range for quarterly Depreciation & Amortization (CF) is -$1,000 (Q3 2025) to $98,000 (Q3 2023).
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2022 (growth of 46.9%), and the weakest in Q4 2025 (a decline of 96.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Matinas BioPharma Holdings | 16.34 Mn | 3.74 Mn | - | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 90,000.00 |
| Mar 31, 2024 | 94,000.00 |
| Dec 31, 2023 | 97,000.00 |
| Sep 30, 2023 | 98,000.00 |
| Jun 30, 2023 | 97,000.00 |
| Mar 31, 2023 | 93,000.00 |
| Dec 31, 2022 | 93,000.00 |
| Sep 30, 2022 | 89,000.00 |
| Jun 30, 2022 | 86,000.00 |
| Mar 31, 2022 | 69,000.00 |
| Dec 31, 2021 | 64,579.00 |
| Sep 30, 2021 | 62,219.00 |
| Jun 30, 2021 | 58,555.00 |
API Access
Matinas BioPharma Holdings Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();